dbcve.org
Life Sciences Central CodingApplication · Oracle

CVE-2026-21980

MEDIUM · 6.5 CVSS v3.1 Published 2026-01-20
Mitigation only
No fix yet — a mitigation exists. There is no fixed release. A documented workaround reduces exposure in the meantime.
See remediation →
74/100
Remediation priority · Elevated
Remotely reachable No privileges Zero-click

Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.

NVD · unedited
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.

dbcve analysis · moderate confidence

Unauthenticated HTTP vulnerability in Oracle Life Sciences Central Coding platform component version 7.0.1.0 allows remote attackers to bypass authentication and gain unauthorized read, insert, update, or delete access to certain application data via network requests.

MitigationApply Oracle's published security patch for this vulnerability; until then, restrict network access to the application via firewall/WAF rules and monitor for anomalous HTTP traffic patterns.

Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.

Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.

NVD · CPE data
Life Sciences Central CodingApplication
Affected:= 7.0.1.0

CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.

From the vector
Attack vector
Network
Complexity
Low
Privileges
None
User interaction
None
Scope
Unchanged
Confidentiality
Low
Integrity
Low
Availability
None

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.

dbcve checks

Work through these to decide whether this CVE applies to you.

  1. Identify Oracle Life Sciences Central Coding installation
    Locate the Oracle Life Sciences Central Coding application in your environment. Check installed programs, application inventory, or deployment records to confirm this product is present.
    Affected if The product is not installed in your environment, you are not affected.
  2. Verify the installed version is 7.0.1.0
    Check the installed version of Oracle Life Sciences Central Coding against the affected version 7.0.1.0. Use the application's about page, version command, or deployment documentation to confirm the exact version number.
    Affected if Your installed version is exactly 7.0.1.0 - you are potentially affected.
  3. Confirm HTTP interface is accessible
    Determine if the application's HTTP/HTTPS interface is network-accessible. Check firewall rules, network segmentation, and whether the application listens on HTTP ports.
    Affected if The HTTP interface is exposed to network users without additional authentication barriers, exploitation is possible.
  4. Review HTTP access logs for unauthorized requests
    Examine web server and application logs for unusual HTTP requests that bypass authentication, especially POST or PUT requests to data endpoints without valid session tokens.
    Affected if Logs show successful HTTP requests to sensitive endpoints that lack proper authentication credentials.

You are affected only if Oracle Life Sciences Central Coding version 7.0.1.0 is installed and its HTTP interface is network-accessible.

Generated from the published advisory. Verify against your own configuration.

Check your environment

Paste your version and any relevant configuration and it will be compared against the affected criteria above. Do not include secrets or credentials.

AI-assisted, checked against the advisory. Informational, not a guarantee.

Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.

From vendor data
Mitigation available No clean upgrade yet — mitigate in the meantime
Mitigation

Apply Oracle's published security patch for this vulnerability; until then, restrict network access to the application via firewall/WAF rules and monitor for anomalous HTTP traffic patterns.

Fix this in Life Sciences Central Coding Scoped from the published advisory
  • Consultation6.0 h
  • Implementation8.0 h
  • Testing12.0 h
  • Review / QA6.0 h
32.0 hours of engineering $5,520
Get help mitigating

An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $8,832.

Scan for this in your stack

Free · runs locally
dbcve dependency scanner

Check whether your project pulls in CVE-2026-21980 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.

Get it on GitHub Scan in the browser

References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.

Primary sources

Practitioner notes

Contributed

Peer-ranked notes from engineers who’ve handled CVE-2026-21980 in production — separate from our analysis above.

No notes yet

Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.

What this is

A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.

What belongs here
  • Verified mitigations, workarounds, and config changes
  • Version or environment caveats, and links to real fixes
  • No weaponised exploit code, or anything meant to cause harm
  • No spam, self-promotion, credentials, or personal data